The Problem with Traditional Ashwagandha Dosing
For many formulators, high-dose ashwagandha extracts (300–600 mg) present well-known challenges in capsule space, serving size, and blend flexibility. Ashwa.30™ by natural Remedies, changes that equation. With clinically validated outcomes at just 30 mg/day, Ashwa.30™ delivers equivalent functional benefits at roughly 90% lower inclusion rates, opening up significant new latitude for formula architecture, delivery formats, and multi-active stacking.
Solving Capsule and Delivery Format Limitations
As you’re fully aware, 600 mg of ashwagandha extract approaches or exceeds the functional fill limit of a standard “00” capsule, often forcing difficult decisions on capsule size, count, or stacking trade-offs. At 30 mg, Ashwa.30™ occupies only a fraction of that footprint, allowing space for synergists, co-actives, or targeted complexes — all while preserving full clinical dose integrity.
Better Fit for Powders, Gummies, and Functional Foods
For powders, gummies, stick packs, and functional foods, the lower inclusion solves longstanding bulk density, flavor, and sensory issues tied to traditional ashwagandha loads. Flowability, blend uniformity, and processing consistency all benefit as well.
Cost Advantages Without Sacrificing Clinical Strength
From an economic standpoint, Ashwa.30™ supports improved cost-of-goods structure without sacrificing label strength. For brands seeking to promote “clinically studied” ashwagandha claims typically tied to 600 mg, Ashwa.30™ provides a data-backed alternative at just 30 mg — fully substantiated by randomized, placebo-controlled human trials.
Powered by Bioactive Optimization Technology™
Powered by Bioactive Optimization Technology™ (B.O.T) delivering >15% withanolides and >15% ATP-active fractions, Ashwa.30™ creates a distinct advantage for stress resilience, performance, and formulation freedom — all in a dramatically smaller dose.
To learn more about Ashwa.30™ click here.